Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.
Business & Industry
- Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union
- Lilly and Amgen announce manufacturing collaboration for COVID-19 antibody therapies
- Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
- COVID-19 vaccine AZD1222 clinical trials resumed in the UK
- CureVac expected to receive up to 252 million euros from the German Federal Ministry of Research for further COVID-19 vaccine development and production capacity expansion
Research & Development
- Web resources bring new insight into COVID-19
- Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility
- Researchers uncover early results about an existing tuberculosis vaccine that has been hypothesized to help against the coronavirus
- T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
- Designed antiviral proteins inhibit SARS-CoV-2 in the lab
- Progress toward antiviral treatments for COVID-19
- Tiny antibody component highly effective against SARS-COV-2 in animal studies
Conferences & Events
- Total health: Build a better healthcare system
- Don't fall for the 'next best action' trap
- Locking down shape-shifting spike protein aids development of COVID-19 vaccine
- COVID-19 vaccine innovation could dramatically speed up worldwide production
- Wearable Injectors and Connected Devices Conference 2020
- Preparing for the new world of drug safety: Embracing cloud and AI
- Pre-filled Syringes San Francisco Conference 2020
Regulatory Affairs
- FDA issues emergency use authorization for convalescent plasma as potential promising COVID-19 treatment
- FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
- FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
- FDA revokes emergency use authorization for chloroquine and hydroxychloroquine
- Global regulators commit to cooperate on observational research in the context of COVID-19